Bispecific Antibodies Market to Witness Growth Acceleration by 2028
The global bispecific antibodies market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The major factor attributed to the market growth includes the rising prevalence of cancer all over the globe. Presently, there are above 300 drug candidates available for the bispecific antibodies for cancer. Majority of these drug candidates are in their pre-clinical or clinical trial stages. Various medical technology providers and drug developers operating within the global bispecific antibodies for cancer market have entered into strategic collaborations together by signing numerous licensing agreements. These efforts are undertaken to advance the development of promising pipeline drug candidates with unique pharmacological and biological properties in the global bispecific antibodies market.
To Request a Sample of our Report on Bispecific Antibodies Market: https://www.omrglobal.com/request-sample/bispecific-antibodies-market
Cancer had proven to be one of
the most chronic diseases globally which is further responsible for a large
number of fatalities all over the globe. Therefore, as a measure to control
this situation and avoid the further prevalence of cancer, the global bispecific
antibodies market is likely to grow. Due to this, substantial growth in the
number of clinical trials aimed towards the development of potent and advanced
bispecific drugs during the past decade has acted favorably for the global
bispecific antibodies market. These trials have made these drugs a popular as
well as a promising candidate for enhanced treatment of various rare medical
conditions, especially a variety of cancers. Presently, Blincyto, Hemlibra and
Rybrevant are available in the commercial market, which are further likely to
grow in the forecast period.
·
The market number available for – 2022-2028
·
Base year- 2021
·
Forecast period- 2022-2028
Segment Covered-
·
By Drug Type
·
By Indication
·
By Distribution Channel
Regions covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape: Sanofi S.A., AbbVie
Inc., and Pfizer Inc., among others.
A
full Report Bispecific Antibodies Market is Available @ https://www.omrglobal.com/industry-reports/bispecific-antibodies-market
Global Bispecific Antibodies Market Report by Segment
By Drug Type
• Blinatumomab
• Catumaxomab
• Duligotumab
By Indication
• Cancer
• Infectious
Disease
• Inflammatory
and Autoimmune Disorders
• CNS
Disorders
By End-User
• Hospital
Pharmacies
• Retail
Pharmacies
• Drug
Stores
• Online
Pharmacies
Global Bispecific Antibodies Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment